会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 8. 发明授权
    • Benzazepine derivatives
    • 苯扎西平衍生物
    • US4604389A
    • 1986-08-05
    • US732204
    • 1985-05-08
    • Manfred ReiffenKlaus NollJoachim HeiderVolkhard AustelNorbert HauelWalter KobingerChristian Lillie
    • Manfred ReiffenKlaus NollJoachim HeiderVolkhard AustelNorbert HauelWalter KobingerChristian Lillie
    • A61K31/55A61P9/06C07C59/64C07D223/16C07D233/16C07D243/04C07D405/12C07D491/04C07D491/056C07D521/00
    • C07D223/16C07C59/64C07D243/04C07D405/12C07D491/04
    • This invention relates to benzazepine derivatives of formula I ##STR1## wherein A is --CH.sub.2 CH.sub.2 -- or --CH.dbd.CH--;R.sub.1 is hydrogen, chlorine, bromine, C.sub.1 -C.sub.3 alkyl, amino, C.sub.1 -C.sub.3 alkylamino, C.sub.1 -C.sub.3 dialkylamino, acylamino, hydroxy, C.sub.1 -C.sub.3 alkoxy or phenyl C.sub.1 -C.sub.3 alkoxy;R.sub.2 is hydrogen, chlorine, bromine, hydroxy, C.sub.1 -C.sub.3 alkyl, C.sub.1 -C.sub.3 alkoxy or phenyl C.sub.1 -C.sub.3 alkoxy or, together with R.sub.1, can be C.sub.1 -C.sub.3 alkylenedioxy;R.sub.3 is hydrogen, chlorine, bromine or C.sub.1 -C.sub.3 alkoxy;R.sub.4 is hydrogen, benzyl, C.sub.1 -C.sub.3 alkyl or C.sub.3 -C.sub.5 alkenyl;R.sub.5 is hydrogen, halogen, C.sub.1 -C.sub.3 alkyl or C.sub.1 -C.sub.3 alkoxy;R.sub.6 is hydrogen, C.sub.1 -C.sub.3 alkyl or C.sub.1 -C.sub.3 alkoxy or, together with R.sub.5, can be a C.sub.1 -C.sub.2 alkylenedioxy;X is an imino, optionally substituted by a benzyl or C.sub.1 -C.sub.3 alkyl, or is oxygen, sulphur, sulphinyl or sulphonyl;Y is an imino, optionally substituted by a benzyl or C.sub.1 -C.sub.3 alkyl, or is methylene or carbonyl;m and n are each independently 2, 3 or 4; and nontoxic, pharmaceutically acceptable addition salts thereof. These compounds have valuable pharmacological properties, particularly the effect of lowering heart rate and reducing the O.sub.2 requirement of the heart.
    • 本发明涉及式I的苯并氮杂衍生物,其中A是-CH 2 CH 2 - 或-CH = CH-; R1是氢,氯,溴,C1-C3烷基,氨基,C1-C3烷基氨基,C1-C3二烷基氨基,酰氨基,羟基,C1-C3烷氧基或苯基C1-C3烷氧基; R2是氢,氯,溴,羟基,C1-C3烷基,C1-C3烷氧基或苯基C1-C3烷氧基,或与R1一起可以是C1-C3亚烷基二氧基; R3是氢,氯,溴或C1-C3烷氧基; R4是氢,苄基,C1-C3烷基或C3-C5烯基; R5是氢,卤素,C1-C3烷基或C1-C3烷氧基; R 6是氢,C 1 -C 3烷基或C 1 -C 3烷氧基,或与R 5一起可以是C 1 -C 2亚烷基二氧基; X是任选被苄基或C 1 -C 3烷基取代的亚氨基,或是氧,硫,亚磺酰基或磺酰基; Y是任选被苄基或C 1 -C 3烷基取代的亚氨基,或亚甲基或羰基; m和n各自独立地为2,3或4; 和无毒的药学上可接受的加成盐。 这些化合物具有有价值的药理学特性,特别是降低心率并降低心脏O2需求的作用。